Archives

by in
Entry Author Date Location
Pfizer Yields to Rivals in Hep C Drug Race 03/13/13 New York
DARPA Backs Pulmatrix’s Lung Treatment, Adimab Scores More Pharma Partners, Semprus Secures $18M, & More Boston-Area Life Sciences News 12/17/10 Boston
Tough Challenges for Clinical Trials 05/05/10 Boston
Vertex Pursues Drug-Cocktail Strategy, Phase Forward Out To Expand Health IT Empire, Alkermes Awaits FDA Ruling, & More Boston-Area Life Sciences News 03/12/10 Boston
Mullen to Relinquish Biogen Idec Reins, Joule to Test Ethanol Tech, Dicerna to Team with Kyowa Hakko Kirin, & More Boston-Area Life Sciences News 01/06/10 Boston
Vertex and Ironwood Drugs Fare Well in Clinical Trials, Pulmatrix Breathes in $30.2M, IRobot Launches Healthcare Unit, & More Boston-Area Life Sciences News 11/04/09 Boston
Alkermes Anti-Addiction Drug Fares Well in Clinical Trials, Amgen Takes Aim at Drug-Development Success Rate, & More Boston-Area Life Sciences News 10/14/09 Boston
Joule Debuts Biofuel Technology, Genzyme Cleans House, Avila Banks $30M, & More Boston-Area Life Sciences News 07/29/09 Boston
Histogen Reports Hair-Raising Study Results 07/27/09 San Diego
Biogen Idec Buys MS Drug Rights, Immuneering Models Cancer Drug Responses, Hologic Wins Contraceptive Device Approval, & More Boston-Area Life Sciences News 07/08/09 Boston
Icahn Bags Two Biogen Board Seats, Pharma Giants Add $40M to Aileron Coffers, Pulmatrix Proceeds With Tests of Flu-Blocking Aerosol, & More Boston-Area Life Sciences News 06/10/09 Boston
Clinical Data Touts Antidepressant Trial Data 06/02/09 Boston
Genentech Veteran Takes Agios’ Helm, E8 and MIT Take on Navigenics, Genzyme’s Mipomersen Takes Next Step, Alnylam Takes Advantage of Tekmira Technology, & More Boston-Area Life Sciences News 05/28/09 Boston
Infinity Halts Trial of Lead Cancer Drug, Tysabri Sales Short of Projections, Myomo Slashes Staff, & More Boston-Area Life Sciences News 04/22/09 Boston
Dendreon Immune Booster for Prostate Cancer Helps Men Live Longer; Shares Boom 04/14/09 Seattle
Funding Pool Deep for Still River, Cuts in the Offing for Epix and Synta, FDA Approvals Granted for Hologic, & More Boston-Area Life Sciences News 03/18/09 Boston
Vertex Puts up $375M for ViroChem, Nuance Finally Nabs Zi, Proteon Procures $38M, & More Boston-Area Deals News 03/06/09 Boston
Synta Melanoma Drug Trial Halted, Drug Regulators Hand Genzyme Mixed Bag, Ariad and ImmunoGen Reach Milestones, & More Boston-Area Life Sciences News 03/04/09 Boston
Genzyme and Boston Scientific Get Good News From the FDA; Acusphere and Targanta Not So Much; TransMedics Pulls IPO Plug; & More Boston-Area Life Sciences News 12/17/08 Boston
GSK Pays Synta $15M 12/12/08 Boston
Resolvyx Closes in on Clinical Trials, Radius Health Reels in $15M, Luke Zeros in on Public Biotechs’ Bottom Line, & More Boston-Area Life Sciences News 11/26/08 Boston
RXi Tackles RNAi Delivery, Pfizer Launches A Two-Cambridge Stem Cell Effort, Archemix Plows An Alternative Path to the Public Market, & More Boston-Area Life Sciences News 11/20/08 Boston
Adventrx Cuts One-Fourth of Staff, CEO Resigns 10/20/08 San Diego
No Appeal for Boston Scientific, No Luck for CombinatoRx Drug, No Complaints From Harvard, & More Boston-Area Life Sciences News 10/08/08 Boston
Indevus Puts New Acromegaly Treatment Head-to-Head with Novartis Treatment in Phase 3 Trial 09/30/08 Boston
Radius Health is Betting on a Better Treatment for Osteoporosis 04/17/08 Boston
Vertex on the Rise, Sirtris on TV, an IPO (Finally) on the Table, and More Life Sciences News 04/02/08 Boston
Vertex Climbs on Encouraging Early Results From Cystic Fibrosis Drug Trial 03/27/08 Boston
Repligen Launches Trial of Imaging Agent 03/26/08 Boston
Cancer Patient Can Use Newton Firm’s Drug, FDA Says 03/24/08 Boston
Page 1 of 2 next page »